K. A. Porter

4.6k total citations · 3 hit papers
45 papers, 3.7k citations indexed

About

K. A. Porter is a scholar working on Surgery, Transplantation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K. A. Porter has authored 45 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Transplantation and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K. A. Porter's work include Renal Transplantation Outcomes and Treatments (10 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Organ Donation and Transplantation (6 papers). K. A. Porter is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Organ Donation and Transplantation (6 papers). K. A. Porter collaborates with scholars based in United States, United Kingdom and Italy. K. A. Porter's co-authors include Thomas E. Starzl, M. Ho, Ronald Jaffe, C W Putnam, Shunzaburo Iwatsuki, Henry T. Bahnson, M Nalesnik, Byers W. Shaw, Robert L. Hardesty and J. Thomas Rosenthal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

K. A. Porter

45 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

1984 965 citations Thomas E. Starzl, K. A. Porter et al. The Lancet profile →
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

1988 586 citations Ronald Jaffe, Thomas E. Starzl et al. PubMed profile →
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.

1973 301 citations Thomas E. Starzl, A. Francavilla et al. PubMed profile →

Peers

Countries citing papers authored by K. A. Porter

Since Specialization

Citations

This map shows the geographic impact of K. A. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. A. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. A. Porter more than expected).

Fields of papers citing papers by K. A. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. A. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. A. Porter. The network helps show where K. A. Porter may publish in the future.

Co-authorship network of co-authors of K. A. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of K. A. Porter. A scholar is included among the top collaborators of K. A. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. A. Porter. K. A. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrin-only protein 2 limits inflammation but improves protection against bacteria 2017 ·Nature Communications ·Sivakumar Periasamy, K. A. Porter, Maninjay Atianand, Hongnga T. Le, Sarah Earley, (unknown), (unknown), (unknown), Jonathan A. Harton	19
2	Understanding the Intersection of Young Age, Mucosal Injury, and HIV Susceptibility 2016 ·AIDS Research and Human Retroviruses ·K. A. Porter, Jim A. Turpin, Lisa Begg, Gina Brown, Nahida Chakhtoura, Elizabeth Church, Cynthia Grossman, Charles R. Wira, Fulvia Veronese	11
3	The CLRX.1/NOD24 (NLRP2P) pseudogene codes a functional negative regulator of NF-κB, pyrin-only protein 4 2014 ·Genes and Immunity ·K. A. Porter, (unknown), (unknown), Maninjay Atianand, Hamid Sharifi, Jonathan A. Harton	27
4	CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion (154.27) 2011 ·The Journal of Immunology ·K. A. Porter, (unknown), Michael Nekorchuk, James W. Jones, Amy B. Hahn, Carlos de Noronha, Jonathan A. Harton, Karen Duus	1
5	Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag 2010 ·PLoS ONE ·K. A. Porter, (unknown), Annette George, Jonathan A. Harton, Karen Duus	8
6	CIITA Enhances HIV-1 Attachment to CD4+ T Cells Leading to Enhanced Infection and Cell Depletion 2010 ·The Journal of Immunology ·K. A. Porter, (unknown), Michael Nekorchuk, James H. Jones, Amy B. Hahn, Carlos M. C. de Noronha, Jonathan A. Harton, Karen Duus	8
7	Liver function in UK patients with oral lichen planus 1993 ·Clinical and Experimental Dermatology ·(unknown), C Scully, Stephen Porter, K. A. Porter, Elizabeth MacNamara	43
8	Class I and II HLA antigens in British patients with oral lichen planus 1993 ·Oral Surgery Oral Medicine Oral Pathology ·K. A. Porter, P. T. Klouda, C Scully, (unknown), Stephen Porter	24
9	The Kidneys: The Urinary Tract 1992 ·Medical Entomology and Zoology ·K. A. Porter, R. C. B. Pugh, I. D. Ansell	5
10	The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo. 1991 ·PubMed ·A. Francavilla, TE Starzl, Brian I. Carr, Alessandro Azzarone, Giuseppe Carrieri, (unknown), K. A. Porter	15
11	Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient. 1990 ·PubMed ·Jennifer S. Daly, K. A. Porter, Frank K. Chong, (unknown)	30
12	REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY breakdown → 1984 ·The Lancet ·Thomas E. Starzl, K. A. Porter, Shunzaburo Iwatsuki, J. Thomas Rosenthal, Byers W. Shaw, Robert W. Atchison, M Nalesnik, M. Ho, Bartley P. Griffith, T.R. Hakala, Robert L. Hardesty, Ronald Jaffe, Henry T. Bahnson	965
13	Simplification of DNA synthesis by the phosphotriester method 1976 ·Tetrahedron Letters ·Peter Cashion, K. A. Porter, (unknown), Ganesh M. Sathe, (unknown), (unknown), Ernest Jay	14
14	EFFECTS OF INSULIN, GLUCAGON, AND INSULIN/GLUCAGON INFUSIONS ON LIVER MORPHOLOGY AND CELL DIVISION AFTER COMPLETE PORTACAVAL SHUNT IN DOGS 1976 ·The Lancet ·Thomas E. Starzl, K. A. Porter, Kazuo Watanabe, C W Putnam	188
15	Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. 1974 ·PubMed ·Thomas E. Starzl, Makoto Ishikawa, Charles W. Putnam, K. A. Porter, (unknown), Bo S. Husberg, C. G. Halgrimson, G Schröter	113
16	The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation 1967 ·Plastic & Reconstructive Surgery ·Andrew M. Moore, Thomas E. Starzl, Thomas L. Marchioro, K. A. Porter, Yoji Iwasaki, G. James Cerilli	78
17	LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY‐THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 1³/₄–2¹/₂ YEARS AFTER TRANSPLANTATION* 1966 ·Annals of the New York Academy of Sciences ·K. A. Porter, J M Rendall, C. Stolinski, Paul I. Terasaki, Thomas L. Marchioro, TE Starzl	37
18	Obliterative Vascular Changes in Four Human Kidney Homotransplants 1963 ·BMJ ·K. A. Porter, (unknown), K. Owen, J. R. Kenyon, J.F. Mowbray, W. S. Peart	174
19	TRANSFORMATION OF ADULT ALLOGENEIC SMALL LYMPHOCYTES AFTER TRANSFUSION INTO NEWBORN RATS 1962 ·The Journal of Experimental Medicine ·K. A. Porter, E.H. Cooper	55
20	IMMUNE HEMOLYSIS: A FEATURE OF SECONDARY DISEASE AND RUNT DISEASE IN THE RABBIT * 1960 ·Annals of the New York Academy of Sciences ·K. A. Porter	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact